584 related articles for article (PubMed ID: 31182340)
21. High potential to tumor necrosis factor alpha (TNF-alpha) production of thyroid infiltrating T lymphocytes in Hashimoto's thyroiditis: a peculiar feature of destructive thyroid autoimmunity.
Del Prete GF; Tiri A; De Carli M; Mariotti S; Pinchera A; Chretien I; Romagnani S; Ricci M
Autoimmunity; 1989; 4(4):267-76. PubMed ID: 2518830
[TBL] [Abstract][Full Text] [Related]
22. Restriction of PD-1 function by
Sugiura D; Maruhashi T; Okazaki IM; Shimizu K; Maeda TK; Takemoto T; Okazaki T
Science; 2019 May; 364(6440):558-566. PubMed ID: 31000591
[TBL] [Abstract][Full Text] [Related]
23. PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition.
Wu Y; Chen W; Xu ZP; Gu W
Front Immunol; 2019; 10():2022. PubMed ID: 31507611
[TBL] [Abstract][Full Text] [Related]
24. PD-L1.
Kythreotou A; Siddique A; Mauri FA; Bower M; Pinato DJ
J Clin Pathol; 2018 Mar; 71(3):189-194. PubMed ID: 29097600
[TBL] [Abstract][Full Text] [Related]
25. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations.
Jiang Y; Chen M; Nie H; Yuan Y
Hum Vaccin Immunother; 2019; 15(5):1111-1122. PubMed ID: 30888929
[TBL] [Abstract][Full Text] [Related]
26. Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients.
Smith MJ; Rihanek M; Coleman BM; Gottlieb PA; Sarapura VD; Cambier JC
J Autoimmun; 2018 May; 89():82-89. PubMed ID: 29233566
[TBL] [Abstract][Full Text] [Related]
27. Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.
Ai L; Xu A; Xu J
Adv Exp Med Biol; 2020; 1248():33-59. PubMed ID: 32185706
[TBL] [Abstract][Full Text] [Related]
28. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
[TBL] [Abstract][Full Text] [Related]
29. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.
Sivori S; Vacca P; Del Zotto G; Munari E; Mingari MC; Moretta L
Cell Mol Immunol; 2019 May; 16(5):430-441. PubMed ID: 30778167
[TBL] [Abstract][Full Text] [Related]
30. Expression of checkpoint molecules on myeloid-derived suppressor cells.
Ballbach M; Dannert A; Singh A; Siegmund DM; Handgretinger R; Piali L; Rieber N; Hartl D
Immunol Lett; 2017 Dec; 192():1-6. PubMed ID: 28987474
[TBL] [Abstract][Full Text] [Related]
31. Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade.
Koopmans I; Hendriks MAJM; van Ginkel RJ; Samplonius DF; Bremer E; Helfrich W
J Invest Dermatol; 2019 Nov; 139(11):2343-2351.e3. PubMed ID: 31128201
[TBL] [Abstract][Full Text] [Related]
32. HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status.
Cao J; Brouwer NJ; Jordanova ES; Marinkovic M; van Duinen SG; de Waard NE; Ksander BR; Mulder A; Claas FHJ; Heemskerk MHM; Jager MJ
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1005-1015. PubMed ID: 29450544
[TBL] [Abstract][Full Text] [Related]
33. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy.
Lin S; Huang G; Cheng L; Li Z; Xiao Y; Deng Q; Jiang Y; Li B; Lin S; Wang S; Wu Q; Yao H; Cao S; Li Y; Liu P; Wei W; Pei D; Yao Y; Wen Z; Zhang X; Wu Y; Zhang Z; Cui S; Sun X; Qian X; Li P
MAbs; 2018; 10(8):1301-1311. PubMed ID: 30204048
[TBL] [Abstract][Full Text] [Related]
34. Role of immune-checkpoint inhibitors in lung cancer.
Jain P; Jain C; Velcheti V
Ther Adv Respir Dis; 2018; 12():1753465817750075. PubMed ID: 29385894
[TBL] [Abstract][Full Text] [Related]
35. The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis.
Weetman AP; Volkman DJ; Burman KD; Margolick JB; Petrick P; Weintraub BD; Fauci AS
Clin Immunol Immunopathol; 1986 Apr; 39(1):139-50. PubMed ID: 3485022
[TBL] [Abstract][Full Text] [Related]
36. EV PD-L1 is Correlated With Clinical Features and Contributes to T Cell Suppression in Pediatric Thyroid Cancer.
Wang G; He L; Wang S; Zhang M; Li Y; Liu Q; Sun N; Zhang X; Liu Y; Zhang J; Tai J; Ni X
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32459310
[TBL] [Abstract][Full Text] [Related]
37. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Kassal H; Waldhäusl W; Feldmann M
J Clin Invest; 1988 May; 81(5):1608-14. PubMed ID: 3130398
[TBL] [Abstract][Full Text] [Related]
38. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function.
Jones D; Como CN; Jing L; Blackmon A; Neff CP; Krueger O; Bubak AN; Palmer BE; Koelle DM; Nagel MA
PLoS Pathog; 2019 Mar; 15(3):e1007650. PubMed ID: 30870532
[TBL] [Abstract][Full Text] [Related]
39. Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXR
You W; Li L; Sun D; Liu X; Xia Z; Xue S; Chen B; Qin H; Ai J; Jiang H
Cancer Immunol Res; 2019 Jun; 7(6):990-1000. PubMed ID: 30975694
[TBL] [Abstract][Full Text] [Related]
40. Blocking of the PD-1/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy.
Zhai W; Zhou X; Zhai M; Li W; Ran Y; Sun Y; Du J; Zhao W; Xing L; Qi Y; Gao Y
Sci China Life Sci; 2021 Apr; 64(4):548-562. PubMed ID: 32737851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
